Sulphonylurea dose-response relationships: relation to clinical practice (Q34163158)

31 July 2017

1 reference

title

Sulphonylurea dose-response relationships: relation to clinical practice (English)

1 reference

31 July 2017

Lindblad U

1

1 reference

PubMed ID

11220350

31 July 2017

Melander A

series ordinal

2

1 reference

31 July 2017

1 January 2000

1 reference

Diabetes, Obesity and Metabolism

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

1

1 reference

31 July 2017

25-31

1 reference

Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotype

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Influence of Food Intake on Presystemic Clearance of Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Interaction of ethanol and glipizide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Slow elimination of glyburide in NIDDM subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Clinical profile of glimepiride

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Plasma chlorpropamide: a critical factor in chlorpropamide-alcohol flush

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Glucose tolerance and mortality, including a substudy of tolbutamide treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Therapeutic equivalence of once- and thrice-daily glipizide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Impaired effect of sulfonylurea following increased dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00046.X

10.1046/J.1463-1326.2000.00046.X

21 January 2018

Identifiers

DOI

1 reference

release_ggtb5rm7o5ci5cvg47rmiq3fom

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ggtb5rm7o5ci5cvg47rmiq3fom

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

11220350

1 reference

PubMed ID

11220350